Show simple item record

dc.contributor.authorMwanza-Lisulo, Men_US
dc.contributor.authorKelly, Pen_US
dc.date.accessioned2015-12-17T13:08:38Z
dc.date.accessioned2016-04-20T12:37:53Z
dc.date.issued2015-06-19en_US
dc.date.submitted2016-02-03T09:59:56.456Z
dc.identifier.issn0962-8436en_US
dc.identifier.otherARTN 20140145en_US
dc.identifier.otherARTN 20140145en_US
dc.identifier.otherARTN 20140145en_US
dc.identifier.otherARTN 20140145en_US
dc.identifier.otherARTN 20140145en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11911
dc.description.sponsorshipM.M.-L. is funded by the Bill & Melinda Gates Foundation.en_US
dc.relation.ispartofPHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCESen_US
dc.relation.replaceshttp://qmro.qmul.ac.uk/xmlui/handle/123456789/9911
dc.relation.replaces123456789/9911
dc.subjectvaccinesen_US
dc.subjectretinoic aciden_US
dc.subjectadjuvantsen_US
dc.subjectvitamin Aen_US
dc.titlePotential for use of retinoic acid as an oral vaccine adjuvanten_US
dc.typeArticle
dc.rights.holderThis is the peer reviewed version of the following article: Mwanza-Lisulo, Mpala, and Paul Kelly. "Potential for use of retinoic acid as an oral vaccine adjuvant." Philosophical Transactions of the Royal Society of London B: Biological Sciences 370.1671 (2015): 20140145. APA, which has been published in final form at http://10.1098/rstb.2014.0145. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
dc.rights.holder© 2015 The Author(s)
dc.identifier.doi10.1098/rstb.2014.0145en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000355575800008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue1671en_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume370en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record